Arcutis Biotherapeutics Inc (NAS:ARQT)
$ 10.82 0.42 (4.04%) Market Cap: 1.27 Bil Enterprise Value: 1.14 Bil PE Ratio: 0 PB Ratio: 8.08 GF Score: 36/100

Q2 2023 Arcutis Biotherapeutics Inc Earnings Call Transcript

Aug 08, 2023 / 08:30PM GMT
Release Date Price: $9.83 (+2.61%)
Operator

Good day, and thank you for standing by. Welcome to the Arcutis Biotherapeutics' Second Quarter 2023 Conference Call. (Operator Instructions) Please be advised that today's conference call is being recorded. I would now like to hand the conference over to your speaker today, Eric McIntyre, Head of Investor Relations. Please go ahead.

Eric McIntyre
Arcutis Biotherapeutics, Inc. - Head of IR

Thank you, Cory. Good afternoon, everyone, and thank you for joining Arcutis' second quarter earnings call. Slides for today are available on the Investors section of our website. On the call today we have Frank Watanabe, President and CEO; Ayisha Jeter, our Interim Chief Commercial Officer; Patrick Burnett, Chief Medical Officer; and Scott Burrows, Chief Financial Officer.

I'd remind everyone that we will be making forward-looking statements during this call. These statements are subject to certain risks and uncertainties, and actual results may differ materially. We encourage you to review the information disclosed in our latest SEC filings. With that intro, I'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot